I see that
$EPIX is in trouble
so I phoned
The witch doctor, to give the magic words to help
Here was his response:
- you go:
Ooh Eeh Ooh Ah Aah Ting Tang Walla Walla Bing Bang
Ooh Eeh Ooh Ah Aah Tang Walla Walla Bing Bang
Ooh Eeh Ooh Ah Aah Ting Tang Walla Walla Bing Bang
Ooh Eeh Ooh Ah Aah Ting Tang Walla Walla Bing Bang
All right?
Hope that helps
bahahahahahahahahahaha
OINK OINK
oh noooooooooo
$EPIX is in trouble
so I phoned
The witch doctor, to give the magic words to help
Here was his response:
- you go:
Ooh Eeh Ooh Ah Aah Ting Tang Walla Walla Bing Bang
Ooh Eeh Ooh Ah Aah Tang Walla Walla Bing Bang
Ooh Eeh Ooh Ah Aah Ting Tang Walla Walla Bing Bang
Ooh Eeh Ooh Ah Aah Ting Tang Walla Walla Bing Bang
All right?
Hope that helps
bahahahahahahahahahaha
OINK OINK
oh noooooooooo
Recent EPIX News
- Investors in Essa Pharma Inc. (NASDAQ: EPIX) are urged to contact Siskinds LLP about its investigation into a potential class action • PR Newswire (Canada) • 12/05/2025 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/15/2025 04:03:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/15/2025 03:58:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/15/2025 03:55:27 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 10/15/2025 03:09:34 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 10/15/2025 03:07:57 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 10/14/2025 09:30:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/09/2025 11:00:44 AM
- ESSA Announces Completion of Arrangement with XenoTherapeutics • PR Newswire (US) • 10/09/2025 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/06/2025 09:18:38 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/03/2025 10:03:39 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2025 10:02:22 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 09/30/2025 08:30:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/30/2025 08:30:53 PM
- ESSA Pharma Inc. Provides Update on its Application to the Supreme Court of British Columbia for Amended Interim Order • PR Newswire (Canada) • 09/30/2025 08:30:00 PM
- ESSA Pharma Inc. Provides Update on its Application to the Supreme Court of British Columbia for Amended Interim Order • PR Newswire (US) • 09/30/2025 08:30:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 09/25/2025 09:08:24 PM
- ESSA Pharma Lowers XenoTherapeutics Merger Payout, Shares Fall 17% • IH Market News • 09/24/2025 12:47:55 PM
